Logo image of GVS.MI

GVS SPA (GVS.MI) Stock Fundamental Analysis

BIT:GVS - IT0005411209 - Common Stock

4.465 EUR
0 (-0.11%)
Last: 9/11/2025, 9:31:38 AM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to GVS. GVS was compared to 58 industry peers in the Health Care Equipment & Supplies industry. GVS has a medium profitability rating, but doesn't score so well on its financial health evaluation. GVS is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year GVS was profitable.
In the past year GVS had a positive cash flow from operations.
GVS had positive earnings in each of the past 5 years.
Each year in the past 5 years GVS had a positive operating cash flow.
GVS.MI Yearly Net Income VS EBIT VS OCF VS FCFGVS.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

1.2 Ratios

GVS has a Return On Assets (3.59%) which is comparable to the rest of the industry.
With a decent Return On Equity value of 7.40%, GVS is doing good in the industry, outperforming 62.07% of the companies in the same industry.
GVS's Return On Invested Capital of 5.89% is fine compared to the rest of the industry. GVS outperforms 60.34% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for GVS is below the industry average of 8.86%.
The last Return On Invested Capital (5.89%) for GVS is above the 3 year average (5.58%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.59%
ROE 7.4%
ROIC 5.89%
ROA(3y)2.47%
ROA(5y)7.49%
ROE(3y)6.28%
ROE(5y)14.78%
ROIC(3y)5.58%
ROIC(5y)11.73%
GVS.MI Yearly ROA, ROE, ROICGVS.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

The Profit Margin of GVS (7.79%) is comparable to the rest of the industry.
GVS's Profit Margin has declined in the last couple of years.
The Operating Margin of GVS (13.71%) is better than 63.79% of its industry peers.
In the last couple of years the Operating Margin of GVS has declined.
The Gross Margin of GVS (56.27%) is comparable to the rest of the industry.
GVS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 13.71%
PM (TTM) 7.79%
GM 56.27%
OM growth 3Y-17.84%
OM growth 5Y-7.16%
PM growth 3Y-26.97%
PM growth 5Y-11.75%
GM growth 3Y-3.53%
GM growth 5Y-1.47%
GVS.MI Yearly Profit, Operating, Gross MarginsGVS.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

3

2. Health

2.1 Basic Checks

GVS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, GVS has more shares outstanding
GVS has more shares outstanding than it did 5 years ago.
GVS has a better debt/assets ratio than last year.
GVS.MI Yearly Shares OutstandingGVS.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
GVS.MI Yearly Total Debt VS Total AssetsGVS.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 2.31 indicates that GVS is not a great score, but indicates only limited risk for bankruptcy at the moment.
GVS has a Altman-Z score (2.31) which is comparable to the rest of the industry.
The Debt to FCF ratio of GVS is 5.44, which is a neutral value as it means it would take GVS, 5.44 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 5.44, GVS perfoms like the industry average, outperforming 56.90% of the companies in the same industry.
GVS has a Debt/Equity ratio of 0.58. This is a neutral value indicating GVS is somewhat dependend on debt financing.
GVS's Debt to Equity ratio of 0.58 is on the low side compared to the rest of the industry. GVS is outperformed by 67.24% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 5.44
Altman-Z 2.31
ROIC/WACC0.83
WACC7.13%
GVS.MI Yearly LT Debt VS Equity VS FCFGVS.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

GVS has a Current Ratio of 1.72. This is a normal value and indicates that GVS is financially healthy and should not expect problems in meeting its short term obligations.
GVS has a Current ratio of 1.72. This is comparable to the rest of the industry: GVS outperforms 50.00% of its industry peers.
A Quick Ratio of 1.25 indicates that GVS should not have too much problems paying its short term obligations.
GVS has a Quick ratio of 1.25. This is comparable to the rest of the industry: GVS outperforms 56.90% of its industry peers.
Industry RankSector Rank
Current Ratio 1.72
Quick Ratio 1.25
GVS.MI Yearly Current Assets VS Current LiabilitesGVS.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

5

3. Growth

3.1 Past

GVS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 32.25%, which is quite impressive.
Measured over the past 5 years, GVS shows a small growth in Earnings Per Share. The EPS has been growing by 0.08% on average per year.
The Revenue has been growing slightly by 1.69% in the past year.
GVS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.51% yearly.
EPS 1Y (TTM)32.25%
EPS 3Y-21.12%
EPS 5Y0.08%
EPS Q2Q%-80%
Revenue 1Y (TTM)1.69%
Revenue growth 3Y8.22%
Revenue growth 5Y13.51%
Sales Q2Q%3.19%

3.2 Future

GVS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.71% yearly.
Based on estimates for the next years, GVS will show a small growth in Revenue. The Revenue will grow by 4.99% on average per year.
EPS Next Y8.87%
EPS Next 2Y16.3%
EPS Next 3Y14.71%
EPS Next 5YN/A
Revenue Next Year3.43%
Revenue Next 2Y4.46%
Revenue Next 3Y4.99%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
GVS.MI Yearly Revenue VS EstimatesGVS.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
GVS.MI Yearly EPS VS EstimatesGVS.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0.1 0.2 0.3 0.4 0.5

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 29.77, GVS can be considered very expensive at the moment.
65.52% of the companies in the same industry are more expensive than GVS, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.03, GVS is valued at the same level.
Based on the Price/Forward Earnings ratio of 13.48, the valuation of GVS can be described as correct.
84.48% of the companies in the same industry are more expensive than GVS, based on the Price/Forward Earnings ratio.
GVS is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.54, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 29.77
Fwd PE 13.48
GVS.MI Price Earnings VS Forward Price EarningsGVS.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, GVS is valued cheaply inside the industry as 82.76% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, GVS is valued cheaper than 93.10% of the companies in the same industry.
Industry RankSector Rank
P/FCF 14.13
EV/EBITDA 10.76
GVS.MI Per share dataGVS.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates GVS does not grow enough to justify the current Price/Earnings ratio.
GVS's earnings are expected to grow with 14.71% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.36
PEG (5Y)352.4
EPS Next 2Y16.3%
EPS Next 3Y14.71%

0

5. Dividend

5.1 Amount

GVS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

GVS SPA

BIT:GVS (9/11/2025, 9:31:38 AM)

4.465

0 (-0.11%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-12 2025-11-12
Inst Owners20.13%
Inst Owner ChangeN/A
Ins Owners63%
Ins Owner ChangeN/A
Market Cap844.69M
Analysts75.56
Price Target6.45 (44.46%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-2.21%
Min Revenue beat(2)-6.4%
Max Revenue beat(2)1.99%
Revenue beat(4)1
Avg Revenue beat(4)-1.57%
Min Revenue beat(4)-6.4%
Max Revenue beat(4)1.99%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.32%
PT rev (3m)-2.77%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-14.15%
EPS NY rev (3m)-14.15%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.43%
Revenue NY rev (3m)-2.03%
Valuation
Industry RankSector Rank
PE 29.77
Fwd PE 13.48
P/S 1.97
P/FCF 14.13
P/OCF 8.7
P/B 1.87
P/tB N/A
EV/EBITDA 10.76
EPS(TTM)0.15
EY3.36%
EPS(NY)0.33
Fwd EY7.42%
FCF(TTM)0.32
FCFY7.08%
OCF(TTM)0.51
OCFY11.5%
SpS2.27
BVpS2.38
TBVpS-0.12
PEG (NY)3.36
PEG (5Y)352.4
Profitability
Industry RankSector Rank
ROA 3.59%
ROE 7.4%
ROCE 7.74%
ROIC 5.89%
ROICexc 6.14%
ROICexgc 17.51%
OM 13.71%
PM (TTM) 7.79%
GM 56.27%
FCFM 13.95%
ROA(3y)2.47%
ROA(5y)7.49%
ROE(3y)6.28%
ROE(5y)14.78%
ROIC(3y)5.58%
ROIC(5y)11.73%
ROICexc(3y)7.42%
ROICexc(5y)17.74%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)7.34%
ROCE(5y)15.42%
ROICexcg growth 3Y-16.96%
ROICexcg growth 5Y-11.72%
ROICexc growth 3Y-26.6%
ROICexc growth 5Y-19.5%
OM growth 3Y-17.84%
OM growth 5Y-7.16%
PM growth 3Y-26.97%
PM growth 5Y-11.75%
GM growth 3Y-3.53%
GM growth 5Y-1.47%
F-Score9
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 5.44
Debt/EBITDA 2.53
Cap/Depr 84.34%
Cap/Sales 8.72%
Interest Coverage 250
Cash Conversion 94.27%
Profit Quality 179.13%
Current Ratio 1.72
Quick Ratio 1.25
Altman-Z 2.31
F-Score9
WACC7.13%
ROIC/WACC0.83
Cap/Depr(3y)69.47%
Cap/Depr(5y)94.36%
Cap/Sales(3y)7.08%
Cap/Sales(5y)7.35%
Profit Quality(3y)312.64%
Profit Quality(5y)218.33%
High Growth Momentum
Growth
EPS 1Y (TTM)32.25%
EPS 3Y-21.12%
EPS 5Y0.08%
EPS Q2Q%-80%
EPS Next Y8.87%
EPS Next 2Y16.3%
EPS Next 3Y14.71%
EPS Next 5YN/A
Revenue 1Y (TTM)1.69%
Revenue growth 3Y8.22%
Revenue growth 5Y13.51%
Sales Q2Q%3.19%
Revenue Next Year3.43%
Revenue Next 2Y4.46%
Revenue Next 3Y4.99%
Revenue Next 5YN/A
EBIT growth 1Y15.17%
EBIT growth 3Y-11.09%
EBIT growth 5Y5.39%
EBIT Next Year54.25%
EBIT Next 3Y22.95%
EBIT Next 5YN/A
FCF growth 1Y-18.55%
FCF growth 3Y22.79%
FCF growth 5Y7.4%
OCF growth 1Y-4.37%
OCF growth 3Y20.52%
OCF growth 5Y12.09%